← FDA Drug Approvals (Drugs@FDA)
OMEPRAZOLE MAGNESIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-04-28
Drug application
- FDA Application #
ANDA213201- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OMEPRAZOLE MAGNESIUM
- Generic name
- OMEPRAZOLE
- Active ingredients
- OMEPRAZOLE MAGNESIUM
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA LTD
- Manufacturer
- Aurohealth LLC
- First approval
- 2023-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown